Phase II Trial of Weekly Docetaxel (Taxotere) and Monthly Cisplatin Chemotherapy as Adjuvant Treatment for Patients With Completely Resected Non-Small Cell Lung Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 May 2018
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 17 Jul 2007 Status changed changed from recruiting to in progress.
- 23 Aug 2006 New trial record.